KRW 13080.0
(1.63%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 15.04 Billion KRW | -64.97% |
2022 | 42.95 Billion KRW | 95.7% |
2021 | 21.94 Billion KRW | -45.54% |
2020 | 40.3 Billion KRW | 402.65% |
2019 | 8.01 Billion KRW | -4.54% |
2018 | 8.39 Billion KRW | 14.16% |
2017 | 7.35 Billion KRW | 10.74% |
2016 | 6.64 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 18.66 Billion KRW | 31.81% |
2024 Q1 | 14.15 Billion KRW | -5.92% |
2023 Q2 | 17.75 Billion KRW | -15.53% |
2023 Q4 | 15.04 Billion KRW | -12.75% |
2023 Q3 | 17.24 Billion KRW | -2.86% |
2023 Q1 | 21.02 Billion KRW | -51.06% |
2023 FY | 15.04 Billion KRW | -64.97% |
2022 Q4 | 42.95 Billion KRW | 15.69% |
2022 Q3 | 37.13 Billion KRW | 1.58% |
2022 Q2 | 36.55 Billion KRW | 3.18% |
2022 Q1 | 35.42 Billion KRW | 61.4% |
2021 Q4 | 21.94 Billion KRW | -29.12% |
2021 Q3 | 30.96 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
InBody Co.,Ltd | 29.41 Billion KRW | 48.848% |
Curexo Inc. | 31.77 Billion KRW | 52.637% |
Seegene, Inc. | 137.63 Billion KRW | 89.067% |
i-SENS, Inc. | 83.54 Billion KRW | 81.987% |
Ray Co., Ltd. | 25.37 Billion KRW | 40.689% |
Gencurix Inc. | 581.02 Million KRW | -2489.912% |
Sugentech Inc. | 7.01 Billion KRW | -114.37% |
L&C Bio Co., Ltd | 46.28 Billion KRW | 67.49% |